These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35882984)

  • 1. Conjunctival Lymphoma.
    McGrath LA; Ryan DA; Warrier SK; Coupland SE; Glasson WJ
    Eye (Lond); 2023 Apr; 37(5):837-848. PubMed ID: 35882984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
    Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
    Celiker H; Toker E; Kaygusuz Atagunduz I
    Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favourable response to rituximab by an ocular adnexal primary lymphoma.
    Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
    Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant lymphoma of the conjunctiva.
    Kirkegaard MM; Coupland SE; Prause JU; Heegaard S
    Surv Ophthalmol; 2015; 60(5):444-58. PubMed ID: 26003619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
    Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
    Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
    Nückel H; Meller D; Steuhl KP; Dührsen U
    Eur J Haematol; 2004 Oct; 73(4):258-62. PubMed ID: 15347312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital Lymphoma-An International Multicenter Retrospective Study.
    Olsen TG; Holm F; Mikkelsen LH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Sjö LD; Vemuganti GK; Thuro BA; Heegaard S
    Am J Ophthalmol; 2019 Mar; 199():44-57. PubMed ID: 30419193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular adnexal lymphoma: Subtype-specific clinical and genetic features.
    Kirkegaard MK
    Acta Ophthalmol; 2022 Oct; 100 Suppl 270():3-37. PubMed ID: 36196757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
    Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
    Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa.
    Nam SW; Woo KI; Kim YD
    Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salmon-pink colored conjunctival tumor with amyloid deposits].
    Müller PL; Loeffler KU; Holz FG; Fischer HP; Herwig MC
    Ophthalmologe; 2016 Jul; 113(7):602-5. PubMed ID: 26362570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
    Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
    Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Conjunctival Extranodal Marginal Zone Lymphoma Treated with Intralesional Rituximab Injection Therapy.
    Yazicioglu T; Oklar M; Kocabas S; Karadag E; Elibol V; Tezcan ME
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1329-1333. PubMed ID: 36084297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia?
    Beykin G; Pe'er J; Amir G; Frenkel S
    Br J Ophthalmol; 2014 May; 98(5):645-50. PubMed ID: 24162623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
    Coupland SE
    Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture.
    Shields CL; Chien JL; Surakiatchanukul T; Sioufi K; Lally SE; Shields JA
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):109-120. PubMed ID: 28399347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.